Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model BR Beck, B Shin, Y Choi, S Park, K Kang Computational and structural biotechnology journal 18, 784-790, 2020 | 896 | 2020 |
Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation SH Park, K Kang, E Giannopoulou, Y Qiao, K Kang, G Kim, KH Park-Min, ... Nature immunology 18 (10), 1104-1116, 2017 | 248 | 2017 |
AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2 H Kim, K Kang, J Kim Nucleic acids research 37 (9), 2940-2950, 2009 | 236 | 2009 |
Interferon-γ represses M2 gene expression in human macrophages by disassembling enhancers bound by the transcription factor MAF K Kang, SH Park, J Chen, Y Qiao, E Giannopoulou, K Berg, A Hanidu, J Li, ... Immunity 47 (2), 235-250. e4, 2017 | 195 | 2017 |
Self-attention based molecule representation for predicting drug-target interaction B Shin, S Park, K Kang, JC Ho Machine learning for healthcare conference, 230-248, 2019 | 194 | 2019 |
A basal-like breast cancer-specific role for SRF–IL6 in YAP-induced cancer stemness T Kim, SJ Yang, D Hwang, J Song, M Kim, S Kyum Kim, K Kang, J Ahn, ... Nature communications 6 (1), 10186, 2015 | 172 | 2015 |
The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer S Yu, T Kim, KH Yoo, K Kang Biochemical and Biophysical Research Communications 486 (3), 752-758, 2017 | 142 | 2017 |
Human histone H3K79 methyltransferase DOT1L methyltransferase binds actively transcribing RNA polymerase II to regulate gene expression SK Kim, I Jung, H Lee, K Kang, M Kim, K Jeong, CS Kwon, YM Han, ... Journal of Biological Chemistry 287 (47), 39698-39709, 2012 | 116 | 2012 |
IFN-γ selectively suppresses a subset of TLR4-activated genes and enhancers to potentiate macrophage activation K Kang, M Bachu, SH Park, K Kang, S Bae, KH Park-Min, LB Ivashkiv Nature communications 10 (1), 3320, 2019 | 108 | 2019 |
Barrier to autointegration factor 1, procollagen‐lysine, 2‐oxoglutarate 5‐dioxygenase 3, and splicing factor 3b subunit 4 as early‐stage cancer decision markers and drivers of … Q Shen, JW Eun, K Lee, HS Kim, HD Yang, SY Kim, EK Lee, T Kim, ... Hepatology 67 (4), 1360-1377, 2018 | 101 | 2018 |
Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration D Yamaji, K Kang, GW Robinson, L Hennighausen Nucleic acids research 41 (3), 1622-1636, 2013 | 89 | 2013 |
MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas JS Kim, EJ Kim, S Lee, X Tan, X Liu, S Park, K Kang, JS Yoon, YH Ko, ... Experimental & molecular medicine 51 (1), 1-10, 2019 | 87 | 2019 |
Hrp3 controls nucleosome positioning to suppress non‐coding transcription in eu‐and heterochromatin YS Shim, Y Choi, K Kang, K Cho, S Oh, J Lee, SIS Grewal, D Lee The EMBO journal 31 (23), 4375-4387, 2012 | 78 | 2012 |
Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules K Kang, GW Robinson, L Hennighausen BMC genomics 14, 1-11, 2013 | 76 | 2013 |
QKI, a miR‐200 target gene, suppresses epithelial‐to‐mesenchymal transition and tumor growth EJ Kim, JS Kim, S Lee, H Lee, JS Yoon, JH Hong, SH Chun, DS Sun, ... International journal of cancer 145 (6), 1585-1595, 2019 | 75 | 2019 |
Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth K Weidenfeld, S Schif-Zuck, H Abu-Tayeh, K Kang, O Kessler, ... Oncotarget 7 (44), 71362, 2016 | 74 | 2016 |
α1‐3/4 fucosylation at Asn 241 of β‐haptoglobin is a novel marker for colon cancer: A combinatorial approach for development of glycan biomarkers SY Park, SH Lee, N Kawasaki, S Itoh, K Kang, S Hee Ryu, N Hashii, ... International Journal of Cancer 130 (10), 2366-2376, 2012 | 69 | 2012 |
Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC) SY Kim, YK Han, JM Song, CH Lee, K Kang, JM Yi, HR Park Clinical Epigenetics 11, 1-12, 2019 | 63 | 2019 |
Chromatin remodeller Fun30Fft3 induces nucleosome disassembly to facilitate RNA polymerase II elongation J Lee, E Shik Choi, H David Seo, K Kang, JM Gilmore, L Florens, ... Nature communications 8 (1), 14527, 2017 | 61 | 2017 |
Octopus-toolkit: a workflow to automate mining of public epigenomic and transcriptomic next-generation sequencing data T Kim, HD Seo, L Hennighausen, D Lee, K Kang Nucleic acids research 46 (9), e53-e53, 2018 | 59 | 2018 |